Showing posts sorted by date for query Freakonomics. Sort by relevance Show all posts
Showing posts sorted by date for query Freakonomics. Sort by relevance Show all posts

Tuesday, September 24, 2024

Abundant: a moving documentary about living organ donors

This past weekend I streamed a preview of a new movie about  living organ donors, kidneys (mostly) and some livers. It's called Abundant, and early in the project it described itself as "a documentary about the human experience of giving."

The movie consists mostly of the stories of donors, the experiences they had, and how they felt and feel about the lives they saved, and their connection to other donors, who are able to share the profound satisfaction that donation has given them. The stories are interspersed with commentary from various kinds of experts. (I was on the preview list since I get a good 60 seconds of commentary:)

The movie is also about chains, starting with kidney exchange chains, since many of the donors are nondirected donors who started chains.

At a more metaphorical level, the movie talks about chains of connections. One of the people they interview is Stephen Dubner, the host of the podcast Freakonomics.  He interviewed me on Freakonomics about kidney exchange, that podcast was heard by Ned Brooks, who was moved to donate a kidney (which started a chain) and then to start the National Kidney Donor Organization (NKDO).  Dubner interviewed him on Freakonomics too, and those Freakonomics interviews contributed more links to the chain.

This movie is destined to be a link in that chain too.

With more than half a million people on dialysis in the U.S., almost everyone knows or knows of someone who needs a kidney transplant.  This is the movie for all of them, with stories that may help them find a donor.  And who knows how many people will create new links in that chain.

It's a movie about how generosity creates abundance.

#############

earlier:

Wednesday, February 21, 2024

Friday, February 26, 2016


Thursday, August 1, 2024

Time banking

 Here's the latest Freakonomics podcast, on time banking. Dubner interviews some proponents, and a skeptic. I was the skeptic. It's not that I think time banking is a bad idea, I think it's a good idea, but a good idea like Esperanto, not a good idea like money... 

The World’s Most Valuable Unused Resource. It’s not oil or water or plutonium — it’s human hours. We’ve got an idea for putting them to use, and for building a more human-centered economy. But we need your help.

One of the proponents is Andrew Yang.

Here's an excerpt from the transcript

"YANG: Yeah, the best example I can use is that punch card at your local deli where you get 10 sandwiches, and you get the 11th for free. That has a place of honor in your wallet. And you get really excited when you get close to the free sandwich. If you can imagine a version of the deli punch card for showing up to all sorts of things like that’s the vision. Americans love points. Americans love rewards. Americans love stuff. I have these reward points on my Amex, and it’s mesmerizing, even though right now, it doesn’t cost them anything because I’m not going to redeem it because I’m hoarding for — I don’t know what I’m hoarding for. That’s really the core idea, is that if you give Americans cumulative rewards for doing awesome stuff, you’ll see more awesome stuff.


Okay, so who could possibly be against a scheme that rewards people for doing awesome stuff? Well, there is a certain Nobel Prize-winning economist.


ROTH: Some people’s time might be more valuable than other people’s.


That’s coming up.


*      *      *


As appealing as the idea of time banking is to me, and to Andrew Yang, most economists think that money is a much better measure of value than time. Here, again, is Al Roth.


ROTH: Time is an interesting commodity, and we buy and sell it all the time. When you hire a lawyer, he bills you by the hour. You give him money for his time and expertise. You might hire someone to house-sit for you, and water your plants while you’re away. So we trade time a lot, but not for time. And part of the reason is that time is sort of a clunky commodity. It’s a lot easier to trade other things.


DUBNER: But why is it so clunky? I mean, just as a dollar is a dollar, an hour is an hour.


ROTH: Well, one of the things we worry about with monetary markets is, some people have more dollars than other people do, and that gives them more access. And maybe we don’t always feel great about that. And so I think some of the charm to people who are charmed by time banks is that everyone has 24 hours in a day. But, you know, a working mother of three kids has less time than a retired banker who has a cleaner coming to his house, and a gardener. So not everyone has the same amount of time. And it’s clunky because it’s also hard to transfer. There’s the joke about the lawyer who goes to see a dentist, and the dentist fills his cavity in 10 minutes. The lawyer says to him, “You make more per hour than I do.” And the dentist says, “Would you prefer that I took an hour?”


DUBNER: So we solicited a few other economists to come on the show to talk about time banking. One of them, who shall go unnamed, wrote back to say: “The more I think about it, the more I think it is the dumbest idea in the world.” So do you hate the idea as much as that economist?


ROTH: I don’t hate it as much as that economist. By and large, I think that finding more opportunities for valuable exchange, for exchange that improves welfare on both sides, is a good thing. So I certainly have nothing against swapping time for time. I just don’t think of it as a scalable way to run a significant part of the economy.


DUBNER: The reason the idea appeals to me is because I’ve spent a lot of time with people like you, economists. And when you get a little bit off the beaten path, you start thinking about things like shadow time, right, the hours I have when I’m not on the clock, and what they’re worth to me and how I could spend them. And then I also just think about human capital, which economists are always going on and on about. It feels like that’s the purpose of a lot of economic research these days, is to show how important it is for people to build human capital through education and social networks and so on, because human capital is indeed really valuable. But then when I look around the world, I see so much surplus, dare I say, wasted human capital. People who are able to do things that may not be that valuable in a regular market circumstance, and may not even be that valuable to them, but might be very valuable to other people. And wouldn’t it be wonderful to find a way to give value to that surplus human capital? I mean, if you add it all up, that could be the biggest natural resource in the world, worth more than all the petroleum and other mineral products combined. And then I thought, well, who out there in the world would appreciate that more than Al Roth, who recognized that there is surplus sitting around in people’s bodies, for instance, in the form of a second kidney, and found a way to set up a system to make those extra kidneys available. So does that make time banking a tad more viable in your view?


ROTH: Well, I already said that I am in favor of looking for ways to increase valuable exchanges. So when time for time works, that’s great. But when you talk about human capital, you’re already suggesting that on some tasks, some people’s time might be more valuable than other people’s, because they have more human capital. And that’s what makes time clunky, if all we’re doing is swapping time. You know, I live on a college campus, so we trade time all the time, by inviting people to dinner. And then they invite us back to dinner. Dinner is sort of time, you expect you’re going to spend two, two-and-a-half hours with people and create connections that can’t be monetized. And it’s part of what makes life worth living. And if they had to eat and run, it would be a less-successful dinner

...

DUBNER: But I could imagine a scenario where, let’s say, there’s a person running a roofing business, maybe they’re second- or third-generation even. And they’ve decided that the way forward is to do solar installations. You’re in California. I’m sure there’s a big market for that there. But they don’t really know how to set up their business to optimize for that. They don’t know what kinds of partnerships, and maybe there’s some tax strategy, and just setting up the business that they’re not clear on. But boy, Professor Roth, he loves to talk to people about problems like that. And he also needs a new roof. So that sounds like a really nice possible exchange that could happen in the time bank. Would you be open to discussing that?


ROTH: I’d be open to discussing it.


DUBNER: He said, reluctantly.


ROTH: I say reluctantly because I certainly wouldn’t want that to be the only way I could get my roof repaired. "

Thursday, June 27, 2024

Freakonomics interviews John Cawley about celebrity advertisements and repugnance (when the celebrity goes bad)

 My email this morning included this announcement:

"Thank you for sitting down with Freakonomics Radio to discuss your work. The episode "Your Brand’s Spokesperson Just Got Arrested — Now What?" includes your interview and has just been released. You can listen and find the transcript on our website here, or download on Apple Podcasts, Spotify, or wherever you get your podcasts. We will be posting the episode on our Twitter, Facebook, and LinkedIn pages and would love it if you could share it on your social media as well."

The episode interviews John Cawley about this paper:

The Role of Repugnance in Markets: How the Jared Fogle Scandal Affected Patronage of Subway  by John Cawley, Julia Eddelbuettel, Scott Cunningham, Matthew D. Eisenberg, Alan D. Mathios & Rosemary J. Avery NBER WORKING PAPER 31782 DOI 10.3386/w31782  October 2023

And they chat with me a bit about repugnance.

I had blogged about that paper here:

Saturday, October 21, 2023

 


Friday, January 19, 2024

Incentives and mis-incentives in science (Freakonomics part II)

 Freakonomics has a second post on fraud in science, and you can listen or read the transcript here:

Can Academic Fraud Be Stopped?

Two quotes stood out for me:

1. VAZIRE: Oh, I don’t mind being wrong. I think journals should publish things that turn out to be wrong. It would be a bad thing to approach journal editing by saying we’re only going to publish true things or things that we’re 100 percent sure are true. The important thing is that the things that are more likely to be wrong are presented in a more uncertain way. And sometimes we’ll make mistakes even there. Sometimes we’ll present things with certainty that we shouldn’t have. What I would like to be involved in and what I plan to do is to encourage more post-publication critique and correction, reward the whistleblowers who identify errors that are valid and that need to be acted upon, and create more incentives for people to do that, and do that well.

...

2. BAZERMAN: Undoubtedly, I was naive. You know, not only did I trust my colleagues on the signing-first paper, but I think I’ve trusted my colleagues for decades, and hopefully with a good basis for trusting them. I do want to highlight that there are so many benefits of trust. So, the world has done a lot better because we trust science. And the fact that there’s an occasional scientist who we shouldn’t trust should not keep us from gaining the benefit that science creates. And so one of the harms created by the fraudsters is that they give credibility to the science-deniers who are so often keeping us from making progress in society.


############

Earlier:

Sunday, January 14, 2024

Sunday, January 14, 2024

"Why Is There So Much Fraud in Academia?" Freakonomics interviews Max Bazerman and others

Below is the latest Freakonomics podcast (and transcript), on fraud in academia.  Those most in the headlines weren't available to be interviewed, but their coauthor (and my longtime HBS colleague) Max Bazerman gives his perspective.

Also interviewed are the Data Colada authors/data sleuths Leif Nelson Uri Simonsohn, and Joe Simmons (with some clues about the name of their blog), and Brian Nosek, who founded the prizewinning Center for Open Science (https://www.cos.io/ 

Here it is:

Why Is There So Much Fraud in Academia?  Some of the biggest names in behavioral science stand accused of faking their results. Freakonomics EPISODE 572.

######

And here are two paragraphs from Max's HBS web page (linked above), suggesting more to come:

"I have been connected to one of the most salient episodes of data fabrication in the history of social science – involving the signing first effect alluded to above. I am working on understanding all known social science frauds in this millennium. Social science also struggles with a broader problem, namely the fact that many studies fail to replicate due to faulty research practices that have become common in social science. Most replication failures can be traced back to the original researchers twisting their data to conform to their predictions, rather than from outright fraud. Trying to produce “significant” results, they may run a study multiple times, in a variety of ways, then selectively report the tests that worked and fail to report those that didn’t. The result is the publication of conclusions that do not hold up as accurate. Both problems – outright data fabrication and this reporting bias that shapes results – need to be tackled, so all of us in academia can publish results that are replicable and can help create value in society.

         "The last dozen years have witnessed multiple efforts to reform social science research to make it more credible, reproducible, and trusted. I am writing a book on reforming social science, which will provide an account of recent data fabrications, and highlight strategies to move forward to create more credible and impactful scientific research."

Thursday, July 13, 2023

Laurie Lee interviews me about kidney exchange, repugnance, and more (podcast)

 Laurie Lee interviews me in her podcast Donor Diaries.

https://www.buzzsprout.com/1748941/13094958?t=35 (You don’t have to log in; just click on “Listen Now”.)

***********

Here is her written description:

"Exchanging kidneys is a complicated process that involves multiple collaborations between kidney patients, living donors, transplant centers, insurance companies, airlines and more.  It’s truly remarkable if you stop to think about the number of people and organizations that need to come together to make 1 paired exchange possible.  We only started exchanging kidneys between non-compatible pairs a little over 20 years ago, so it’s a somewhat new process.  Have you ever wondered how this was made possible?

"Meet Nobel Laureate Al Roth who is an economist and Stanford University professor.  Al designs markets.  He’s one of the prominent players who has made kidney exchange possible.  In a nutshell, his work has revolutionized kidney exchange around the world by using economic theory to make kidneys more available.

"In October 2012, Al was the co-recipient of the 2012 Nobel Memorial Prize in Economic Sciences, together with Lloyd S. Shapley, for “ the theory of stable allocations and the practice of market design."

"Al Roth is well known for his application of economics to real world problems.  In this podcast episode we touch a wide range of topics ranging from paired exchanges, prostitution, surrogacy, and more.  All of these markets are examples of repugnant markets.  Kidney Donation can be characterized as a repugnant market, and Al will tell us all about it! 

Links:

Monday, July 10, 2023

Compensating kidney donors: a call to action by Brooks and Cavanaugh in the LA Times

 Here's a clarion call for compensation of living kidney donors, from two nondirected kidney donors.  It's not the first, and very likely not the last, given the difficulty of modifying the existing law.  But it makes the case very clearly (and proposes that a tax credit spread over ten years might be the way to move foreward).

Opinion: A single reform that could save 100,000 lives immediately BY NED BROOKS AND ML CAVANAUGH, JULY 9, 2023 

"Never in the field of public legislation has so much been lost by so many to one law, as Churchill might’ve put it. The National Organ Transplant Act of 1984 created the framework for the organ transplant system in the United States, and nearly 40 years later, the law is responsible for millions of needless deaths and trillions of wasted dollars. The Transplant Act requires modification, immediately.

"We’ve got skin in this game. We both donated our kidneys to strangers. Ned donated to someone who turned out to be a young mother of two children in 2015, which started a chain that helped an additional two recipients. And Matt donated at Walter Reed in 2021, after which his kidney went to a Seattleite, kicking off a chain that helped seven more recipients, the last of whom was back at Walter Reed.

"Ned founded, and Matt now leads, an organization that represents nearly 1,000 living donors

...

"eight years ago, when Ned donated, the number of living kidney donors was 6,000. With all the work we’ve done since, the number of living donors is still about 6,000 annually. In the United States, nearly 786,000 people suffer from end-stage kidney disease, more people than can fit in the 10 largest NFL stadiums combined.

...

"More Americans die of kidney disease than of breast or prostate cancer, and one in three of us is at risk. This illness is widespread, but what makes it worse is the staggering financial burden borne by everyone. The head of the National Kidney Foundation testified in March that Medicare spends an estimated $136 billion, nearly 25% of its expenditures, on the care of people with a kidney disease. Of that, $50 billion is spent on people with end-stage kidney disease, on par with the entire U.S. Marine Corps budget.

...

"The National Organ Transplant Act prohibits compensating kidney donors, which is strange in that in American society, it’s common to pay for plasma, bone marrow, hair, sperm, eggs and even surrogate pregnancies. We already pay to create and sustain life

...

"The ethical concerns regarding compensation are straightforward. Nobody wants to coerce or compel those in desperate financial straits to do something they would not have done otherwise. The challenge, then — until artificial or nonhuman animal substitutes are viable options — is to devise a compensation model that doesn’t exploit donors.

"Compensation models have been proposed in the past. A National Institutes of Health study listed some of the possibilities, including direct payment, indirect payment, “in kind” payment (free health insurance, for example) or expanded reimbursements. After much review, we come down strongly in support of indirect payment, specifically, a $100,000 refundable federal tax credit. The tax credit would be uniformly applied over a period of 10 years, in the amount of $10,000 a year for those who qualify and then become donors.

"This kind of compensation is certainly not a quick-cash scheme that would incentivize an act of desperation. Nor does it commoditize human body parts. Going forward, kidney donation might become partly opportunistic rather than mostly altruistic, as it is now. But would it be exploitative? Not at all."

...

Ned Brooks and ML Cavanaugh are living kidney donors, and Brooks is the founder of the Coalition to Modify NOTA.

********

Here are all my posts that mention Ned Brooks, starting with this one:

Friday, February 26, 2016

Friday, May 26, 2023

Freakonomics replay and update on kidney exchange and organ donation

 Freakonomics Radio yesterday revisited some of their old podcasts about kidney exchange. In one, they interview me, and in another, they interview Ned Brooks, who listened to that interview and went on to become a non-directed kidney donor and to found an organization to support other kidney donors, the NKDO, National Kidney Donation Organization.  You can listen and/or read the transcript at this link:

EPISODE 209

Make Me a Match (Update)

"Sure, markets work well in general. But for some transactions — like school admissions and organ transplants — money alone can’t solve the problem. That’s when you need a market-design wizard like Al Roth. Plus: We hear from a listener who, inspired by this episode, made a remarkable decision.

"Last month, the federal government announced plans to modernize the U.S. organ-donation system. They want to speed up the process by which organ-transplant patients are matched with donated organs, and they also want to reduce racial inequities in the system. When we saw this news, we decided to go into our archive and put together the episode you’re about to hear. It’s a mashup of a 2015 episode, No. 209, called “Make Me a Match,” and a portion of a 2016 episode, No. 237, which includes a personal story from a listener who was inspired by that earlier episode to make a remarkable decision. All the relevant facts and figures have been updated. As always, thanks for listening."

***********

Here are my previous posts on Freakonomics episodes.

Tuesday, November 16, 2021

Freakonomics MD on deceased donor organs for transplants

 Freakonomics MD has a podcast focusing on the scarcity of deceased donor kidneys for transplant, and why recovered organs are sometimes discarded. They interview (separately) Dr. Sumit Mohan at Columbia, and me. (I was in fact interviewed by Jessica Wapner, not by the narrator, Dr. Bapu Jena, using a fancy microphone which they FedExed to me beforehand and I FedExed back to them afterwards...so my snippets probably sound like me...)

You can listen to it right below, or at the link...

x


Why Do So Many Donated Kidneys End Up in the Trash? (Freakonomics, M.D. Ep. 11)

LISTEN NOW:

Every year, thousands of people in the U.S. die while they’re waiting for a new kidney, yet thousands of available organs get thrown away. Bapu talks to a kidney doctor and an economics Nobel laureate about why this happens and how the system could improve.

Follow Freakonomics, M.D. on Apple PodcastsSpotifyStitcher, or wherever you get your podcasts.

Sunday, September 12, 2021

A living kidney donor podcast by Ned Brooks

 Here's a link at which you can hear Ned Brooks, on the latest episode of Donor Diaries

"Ned is a high-profile activist for living kidney donation and the founder of The National Kidney Donors Organization.  Ned’s appearance on Freakonomics podcast and his TEDx Talk on living kidney donation are often mentioned by living kidney donors as an early inspiration for their donation."  

https://www.donordiaries.com/episodes

Tuesday, April 13, 2021

The complex economics of dialysis and insurance, in Freakonomics

 Freakonomics peeks under the rocks to see what crawls out:

Is Dialysis a Test Case of Medicare for All? (Ep. 457)  by Stephen J. Dubner

"But as he dug into their business, he discovered what looked like a suspicious relationship between the two dialysis chains and a charity called the American Kidney Fund, whose mission is to provide financial support to needy patients.

CHANOS: So, the American Kidney Fund will help various patients pay for private policies. 

Private insurance policies, that is, instead of Medicare.

CHANOS: The patient is strongly urged because of quality of care, convenience, whatever the case might be, that they will be treated better as a commercial-policy patient rather than a government-policy patient and that the American Kidney Fund could help them pay those premiums.

On its surface, that does not sound like a terrible thing for a kidney charity to do. But Chanos looked at it from the perspective of the dialysis industry.

CHANOS: If the dialysis companies could push people that would normally be eligible for Medicare into commercial policies, private policies, they could charge those companies often two to four times what the going Medicare reimbursement rate was.

And Chanos believed that pushing people onto commercial insurance is exactly what the American Kidney Fund was doing. It’s helpful here to follow the money.

CHANOS: It will come as probably no shock that the two largest donors to the American Kidney Fund are the two largest dialysis companies, Fresenius and DaVita. 

In 2018, DaVita and Fresenius reportedly donated a combined $247 million to the American Kidney Fund — or about 80 percent of the charity’s revenues.

CHANOS: So, they are basically putting money into the charity. The charity is turning around and using that money to help pay premiums to enroll patients in commercial insurance. And then, the commercial insurers are charged a huge premium to what the dialysis companies are charging the government. 

It’s estimated that for every dollar that DaVita or Fresenius send to the American Kidney Fund, they receive $3.50 in return from private-insurance payments.

CHANOS: And that’s the problem. 

One especially interesting part of this arrangement is who’s losing money: the insurance companies! It’s not often you hear about insurance companies on the losing end — and maybe you don’t have much sympathy.

CHANOS: “Well, it’s the private sector, right? So, why should we care if the insurers make less profits?” Well, the fact of the matter is it’s raising premiums for everybody in the exchanges.

That is, the insurance exchanges, the marketplaces created by the Affordable Care Act, also known as Obamacare.

CHANOS: And the head of California Blue Cross Blue Shield was on the record saying that the dialysis in California was driving up private policy rates dramatically"

Wednesday, December 23, 2020

Celebrating Ramanujan's birthday (with some math quotes)

 Yesterday, 22 December, is celebrated every year as National Mathematics Day in India, in honor of the 1887 birthday of the great Indian mathematician Ramanujan.

Here are some quotes about math in honor of the day, in the Indian periodical RepublicWorld.com

Mathematics Day: Here are some of the most inspirational Happy Mathematics Day quotes on Ramanujan's birthday to honour this special occasion.  By Vageesha Taluja

Not included in that collection of quotes is this one, attributed in Wikipedia to Ramanujan himself: "An equation for me has no meaning unless it expresses a thought of God."

I was pleasantly surprised to see included something much more prosaic that I  was quoted as saying, in a 2010 profile in Forbes magazine called Un-Freakonomics, by Susan Adams: 

"I've always been interested in using mathematics to make the world work better." -Alvin E. Roth

Wednesday, October 21, 2020

National Kidney Donor Advocate Conference, on YouTube

 Here's an announcement I received from Ned Brooks, the founder of  NKDO, National Kidney Donation Organization (formerly Donor to Donor).  If I understand correctly, the different talks and interviews will be available at the link after first streaming in conference style, starting at 9am Pacific time. It includes a video of Ned interviewing me.

I'll update this post as necessary. 


"This Wednesday, October 21st, NKDO, National Kidney Donation Organization (formerly Donor to Donor) will release the virtual National Kidney Donor Advocate Conference. This event is designed to give volunteer living donor advocates the information they need to be more effective advocates for living donation. Transplant industry experts across the country will be presenting to you and delivering invaluable advice about their area of expertise.

The conference will stream on our YouTube channel beginning at 12:00 noon Eastern this Wednesday. The conference will be in segments and accessed through the “playlist”, either streaming as one event or accessed at different points in the conference. The link is  https://www.youtube.com/channel/UCsoS-yavRQCVl7bwcjT2iCA , which will go live at noon Eastern on Wednesday.


- Have you ever wondered about the transplant surgeons who do the surgery? What they are thinking and what they would like you to know? Dr. Joshua Mezrich, transplant surgeon at UWMadison and author of “When Death Becomes Life: Notes from a Transplant Surgeon” talks about his experience with organ donors and recipients.


- Are you a living donor or a transplant recipient, or expecting to be one? Do you remember the experience of being evaluated at the transplant center and listening to all the information, and maybe feeling a little overwhelmed? Living Donor Coordinator Marian Charlton and Patient Coordinator Janet Hiller are two of the most respected voices in transplant, and they will tell you what they want you to know to better understand the process. Anyone who goes through this experience or has a loved one in transplant will want to see these segments.


- Living kidney donors deserve all protections available, from reimbursement for out-of-pocket costs and lost wages to medical coverage for medical issues that may arise months or years after donation. Garet Hil, founder and CEO of the National Kidney Registry, talks about the suite of protections available to living donors through Donor Shield.


-  Are you a kidney patient in need of a donor? Harvey Mysel, a two-time kidney recipient and founder and CEO of the Living Kidney Donor Network, talks about how to have your kidney donor find you.


- Professor Alvin Roth won the Nobel Prize in Economics for his work creating the algorithms that contributed to the creation of the “kidney chain”, a development that transformed kidney transplant procedures. Prof. Roth discusseshis work and the business known by the intriguing moniker of “repugnanttransactions.”


- All kidney patients will benefit by watching nephrologist Dr. David Serur talk about kidney disease and what every kidney patient and advocate needs to know to be properly informed about how to deal with renal disease. 


- Non-directed, or altruistic, donors are a rare breed, though we are trying to change that. No one knows the brain of the non-directed donor better than Professor Abigail Marsh, who has been studying non-directed donors for years. If you want to better understand why someone will happily donate a kidney to a stranger, this presentation will help answer that question.  Prof. Marsh is the author of “The Fear Factor: How One Emotion Connects Altruists, Psychopaths, and Everyone In-Between.”


- If you listen to podcasts, you are probably familiar with “Freakonomics” and its creator, Stephen Dubner. It was the Freakonomics interview with Prof. Roth that set Donor to Donor and NKDO into motion, and our interview with Mr. Dubner will interest anyone who understands “the power of the pod”.


- Jim Gleason is a heart transplant recipient and the president of TRIO, Transplant Recipients International Organization. Mr. Gleason is a motivational speaker who asks the question, “Are you a cookie monster?”



Here's the video of my video

Sunday, October 11, 2020

5000 Market Design blog posts and counting

 Peter Coles and I started this blog in September 2008, to help alert students in our market design class at Harvard that market design was everywhere.  Sometime recently I passed the 5000 posts mark.  It turns out I like to blog about market design, broadly construed. And I'm still teaching market design.

The modal tag on my posts turns out to be repugnance, as I've been fascinated by trying to understand which kinds of transactions and markets get social support and which don't. Various design efforts that I've been involved in also have been the subject of multiple posts, with tags like residents and fellowsschool choice, and kidney exchange

Some of my favorite posts (from an incomplete series, whenever I manage to get a picture) commemorate dissertation defences. And under a variety of tags (such as market designers) I like to mark when students and colleagues are celebrated or win a prize. (I look forward to writing more of those.)

Less fun is the growing number of posts tagged  RIP, in which I note the passing of people with whom I've intersected, mostly but not always in a market design connection.

In the first years of the blog I allowed comments, but after I got involved in kidney exchange, I had to regularly erase comments--typically sprinkled each night among old posts--that offered to buy kidneys, at unrealistically high prices, phishing for fools. So at some point I shut down comments, noted in this post: August 25, 2018  No comment(s)

Here are ten posts from the last five years that caught my eye as I scrolled through them before giving up on the clunky scrolling device:

September 30, 2020 A modest proposal for the design of presidential debates

March 2, 2018 The Economist discusses repugnant transactions